These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2076558)

  • 1. Syntheses of monocyclic and bicyclic 2,4(1H,3H)-pyrimidinediones and their serotonin 2 antagonist activities.
    Watanabe Y; Usui H; Shibano T; Tanaka T; Kanao M
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2726-32. PubMed ID: 2076558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses and 5-HT2 antagonist activity of bicyclic 1,2,4-triazol-3(2H)-one and 1,3,5-triazine-2,4(3H)-dione derivatives.
    Watanabe Y; Usui H; Kobayashi S; Yoshiwara H; Shibano T; Tanaka T; Morishima Y; Yasuoka M; Kanao M
    J Med Chem; 1992 Jan; 35(1):189-94. PubMed ID: 1732528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.
    Robertson DW; Lacefield WB; Bloomquist W; Pfeifer W; Simon RL; Cohen ML
    J Med Chem; 1992 Jan; 35(2):310-9. PubMed ID: 1732548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological studies of N-substituted 6-[(2-aminoethyl)amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinediones, novel class III antiarrhythmic agents.
    Katakami T; Yokoyama T; Miyamoto M; Mori H; Kawauchi N; Nobori T; San-nohe K; Kaiho T; Kamiya J
    J Med Chem; 1992 Sep; 35(18):3325-30. PubMed ID: 1527781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of irindalone, a novel serotonin 5-HT2 antagonist and ketanserin on mechanical responses of rat thoracic aorta.
    Mikkelsen EO; Nyborg NC; Jensen KT; Boeck V
    Eur J Pharmacol; 1988 Apr; 149(1-2):145-8. PubMed ID: 3396624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant activities of phenyl-substituted bicyclic 2,4-oxazolidinediones and monocyclic models. Comparison with binding to the neuronal voltage-dependent sodium channel.
    Brouillette WJ; Brown GB; DeLorey TM; Shirali SS; Grunewald GL
    J Med Chem; 1988 Nov; 31(11):2218-21. PubMed ID: 2846842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HT2 receptor antagonist, pelanserin, inhibits alpha 1-adrenoceptor-mediated vasoconstriction in vitro.
    Villalobos-Molina R; Ibarra M; Hong E
    Eur J Pharmacol; 1995 Apr; 277(2-3):181-5. PubMed ID: 7493607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.
    Gale JD; Grossman CJ; Whitehead JW; Oxford AW; Bunce KT; Humphrey PP
    Br J Pharmacol; 1994 Jan; 111(1):332-8. PubMed ID: 8012715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiserotoninergic activity of 2-aminoethylbenzocyclanones in rat aorta: structure-activity relationships.
    Loza MI; Ferreiro TG; Sanz F; Lozoya E; Rodriguez J; Manaut F; Verde I; Castro E; Fontenla JA; Cadavid I
    J Pharm Sci; 1993 May; 82(5):513-7. PubMed ID: 8360829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient synthesis of bicyclic oxazolino- and thiazolino[3,2-c]pyrimidine-5,7-diones and its application to the synthesis of GnRH antagonists.
    Pontillo J; Chen C
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1407-11. PubMed ID: 15713397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1990 Jul; 254(1):350-5. PubMed ID: 2366187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2-(omega-phenylalkyl)phenoxy]alkylamines: synthesis and dual dopamine2 (D2) and 5-hydroxytryptamine2 (5-HT2) receptor antagonistic activities.
    Tanaka N; Goto R; Ito R; Hayakawa M; Ogawa T; Fujimoto K
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):639-46. PubMed ID: 9579040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
    Killam AL; Nikam SS; Lambert GM; Martin AR; Nelson DL
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1083-9. PubMed ID: 2319460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of DAU 6215, a novel 5-HT3 receptor antagonist, on the cardiovascular system in anaesthetized and pithed rats.
    Malinowska B; Pawlak D; Buczko W
    Agents Actions; 1992 Jul; 36(3-4):230-6. PubMed ID: 1529806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of a new potent 5-hydroxytryptamine antagonist.
    Williams PD; Calligaro DO; Colbert WE; Helton DR; Shetler T; Turk JA; Jordan WH
    Arzneimittelforschung; 1991 Mar; 41(3):189-95. PubMed ID: 1867653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties.
    Hancock AA; Buckner SA; Brune ME; Esbenshade TA; Ireland LM; Katwala S; Milicic I; Meyer MD; Kerwin JF; Williams M
    J Pharmacol Exp Ther; 2002 Feb; 300(2):478-86. PubMed ID: 11805207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Aono J; Nabata H; Ishizuka N; Sakai K
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.